Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X about a recent article he and his colleagues co-authored, adding:
“Results from the CORRELATE study, comparing real world outcomes to clinical trial results with front-line immunotherapy in NSCLC. Found that real world OS was 36%-61% shorter and rwPFS 21%-60% shorter than reference randomized trials.”
Title: Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study
Authors: S. Peters, R.J.-B. Salomonsen, I. Diaz Perez, T. Shcherbakova, A. Wang, L. Cai, S. Sadow, S.V. Liu
Read the Full Article on ESMO Open
More posts featuring Stephen V Liu.